Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT02407912
Eligibility Criteria:
Inclusion Criteria:
* Cytologically proven and previously untreated malignant pleural effusion of Non-small-cell Lung Cancer;
* An Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1;
* A leucocyte count of≥4000µl;
* A platelet count of≥100000µl;
* A normal creatinine level;
* Serum glutamic oxaloacetic transaminase/glutamic pyruvic transaminase levels of no more than twice the upper limit of normal;
* Survival time ≥12 weeks.
Exclusion Criteria:
* Previously treated malignant pleural effusion;
* Pericardial effusion；
* Pregnant；
* Uncontrolled hypertension or diabetes；
* Liver cihrosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02407912
Study Brief:
Protocol Section:
NCT02407912